Predict your next investment

medicalstrategy.de

See what CB Insights has to offer

Investments

7

Portfolio Exits

4

About Medical Strategy

Medical Strategy Headquarter Location

38 Elisabethstraße

80796,

Germany

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Medical Strategy

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Find Medical Strategy in 1 Expert Collection, including Pharma Startups.

P

Pharma Startups

5,090 items

Pharmaceutical companies working across drug discovery, drug development and drug manufacturing.

Latest Medical Strategy News

W Medical Strategy Group Announces Virtual New York Health Forum: “Investing in Space – Next Frontier of Healthcare” on March 16

Mar 4, 2021

March 04, 2021 08:00 AM Eastern Standard Time ENGLEWOOD CLIFFS, N.J.--( BUSINESS WIRE )-- W Medical Strategy Group , a healthcare consulting firm focused on cross-border business transactions, is hosting an upcoming virtual webinar for its New York Health Forum series on Tuesday, March 16, 2021. Details of the virtual panel are below: Title: Investing in Space – Next Frontier of Healthcare Date/Time: March 16, 2021, 12PM - 1PM EST Moderator: Kimberly Ha, CEO at KKH Advisors Panelists: Dr. Mark Ott, Microbiology Lead at Johnson Space Center at NASA Dr. Ji Sun Park, Senior Scientist at Enzychem Lifesciences “I look forward to discussions by thought leaders that lead the way to accelerate progress against space radiation and other space-related health threats in this virtual panel,” said DoHyun Cho, Ph.D., Chairman of New York Health Forum. “We are inspired by the industry’s efforts to move forward in space exploration. In this science forum, we hope to explore areas that are not frequently discussed, to support astronauts and space-related health and wellness during deep space missions. Complimentary registration is available to executives in the biotech and space industry, investors, media and academia via the registration link here . About W Medical Strategy Group W Medical Strategy Group (WMSG) is a cross-border healthcare consulting firm that uses deep industry expertise and to help companies achieve optimal business results. WMSG operates media and distribution divisions to provide enriched platforms to professionals in the healthcare industry. WMSG hosts the New York Health Forum (NYHF), where discussions on the latest trends and issues in healthcare take place. Moreover, WMSG has published and distributed the World Asian Medical Journal (WAMJ), a medical magazine that covers interviews of internationally recognized physicians and entrepreneurs of Asian background, for 23 issues to over 38,000 readers around the world. About New York Health Forum Since 2014, New York Health Forum (NYHF) remains committed to amplifying the life sciences industry’s efforts to develop solutions for patients and lead the discussions on disruptive innovation and continued progress. Contacts

Medical Strategy Investments

7 Investments

Medical Strategy has made 7 investments. Their latest investment was in NOXXON Pharma as part of their Series F on May 5, 2010.

CBI Logo

Medical Strategy Investments Activity

investments chart

Medical Strategy Portfolio Exits

4 Portfolio Exits

Medical Strategy has 4 portfolio exits. Their latest portfolio exit was NOXXON Pharma on September 30, 2016.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

9/30/2016

IPO

1

00/00/0000

Subscribe to see more

Subscribe to see more

$991

Subscribe to see more

10

00/00/0000

Subscribe to see more

Subscribe to see more

$991

Subscribe to see more

10

00/00/0000

Subscribe to see more

Subscribe to see more

$991

Subscribe to see more

10

Date

9/30/2016

00/00/0000

00/00/0000

00/00/0000

Exit

IPO

Subscribe to see more

Subscribe to see more

Subscribe to see more

Companies

Subscribe to see more

Subscribe to see more

Subscribe to see more

Valuation

$991

$991

$991

Acquirer

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

1

10

10

10

Medical Strategy Team

2 Team Members

Medical Strategy has 2 team members, including current Managing Director, Juergen Harter.

Name

Work History

Title

Status

Juergen Harter

Managing Director

Current

Harald Schwarz

Managing Director

Current

Name

Juergen Harter

Harald Schwarz

Work History

Title

Managing Director

Managing Director

Status

Current

Current

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.